News

August 30, 2017

The Impact of Artificial Intelligence on Medical Innovation in the European Union and United States

Intellectual Property & Technology Law Journal, Vol. 29, No. 8

By Lincoln Tsang Daniel A. Kracov Jacqueline Mulryne Louise Strom Nancy L. Perkins Richard Dickinson Victoria M. Wallace

Find more content tagged:

Intellectual Property

Life Sciences and Healthcare Regulatory

Mobile Health and Emerging Technologies

Life Sciences Industry

EU Life Sciences

Stay up-to-date with the latest topics from the firm.

Email Subscriptions RSS Feed (All Perspectives) RSS Feed (News Only)

People

Lincoln Tsang

Lincoln Tsang

Partner

London

+44 (0)20 7786 6104

lincoln.tsang@arnoldporter.com

Daniel A. Kracov

Daniel A. Kracov

Partner

Washington, DC

+1 202.942.5120

daniel.kracov@arnoldporter.com

Jacqueline Mulryne

Jacqueline Mulryne

Counsel

London

+44 (0)20 7786 6123

jacqueline.mulryne@arnoldporter.com

Louise Strom

Louise Strom

Associate

London

+44 (0)20 7786 6224

louise.strom@arnoldporter.com

Nancy L. Perkins

Nancy L. Perkins

Counsel

Washington, DC

+1 202.942.5065

nancy.perkins@arnoldporter.com

Richard Dickinson

Richard Dickinson

Partner

London

+44 (0)20 7786 6213

richard.dickinson@arnoldporter.com

Victoria Wallace

Victoria M. Wallace

Associate

Washington, DC

+1 202.942.5479

victoria.wallace@arnoldporter.com